Aspiriant, LLC Gilead Sciences, Inc. Transaction History

Aspiriant, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$56.65 - $64.55 $539,081 - $614,257	-9,516 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$62.1 - $78.08 $590,943 - $743,009	9,516 New	9,516 $602,000
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $201,539 - $234,024	-2,786 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $174,487 - $223,492	2,786 New	2,786 $209,000
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $224,535 - $247,848	-3,592 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $3,650 - $4,093	-59 Reduced 1.62%	3,592 $241,000
Q1 2019 May 03, 2019	SELL	$62.53 - $70.05 $12,693 - $14,220	-203 Reduced 5.27%	3,651 $236,000
Q4 2018 Feb 04, 2019	BUY	$60.54 - $79.0 $19,736 - $25,754	326 Added 9.24%	3,854 $241,000
Q3 2018 Oct 26, 2018	SELL	$71.28 - $78.92 $62,655 - $69,370	-879 Reduced 19.95%	3,528 $272,000
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $168,039 - $196,011	-2,590 Reduced 37.02%	4,407 $312,000
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $509,661 - $621,333	6,997 New	6,997 $527,000
Q4 2017 Jan 31, 2018	SELL	$71.15 - $83.52 $314,340 - $368,991	-4,418 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $318,581 - $377,606	4,418	4,418 $358,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspiriant, LLC with notifications on news.